Labcorp (LH) Stock: Buy, Sell, or Hold?
LH - Labcorp Holdings Inc.
$323.75
0.62 (0.19%)
▲
5d:
+2.02%
30d:
+3.92%
90d:
+11.25%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 28, 2026
5d
Get Alerted When LH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LH shows conflicting indicators. Wait for confirmation before entering.
LH is flagged by 1 backtest-validated scanner today
SPY Bullish (stocks from this scanner have beaten SPY by a median 0.37% over the next 20 trading days; LH has been on it 1 day). Backtested on 8 months of scanner history vs the S&P 500, as of 2026-10-21.
See all of today's Best Signals in the free scanner →Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$389.66
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$241.95
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LH is currently trading at $323.75, which is considered extended relative to its 30-day fair value range of $308.56 to $321.14. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.4) compared to its historical average (14.8). At these levels, the market is pricing in 3.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LH is in a strong uptrend. The price is approaching resistance at $327.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LH is in a strong uptrend. The price is approaching resistance at $327.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$308.56 -
$321.14
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.3%
Protect Your Profits
Holding LH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($345.12)
- NEUTRAL: Market pricing in 3.5% annual earnings growth - fairly valued
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$308.56 -
$321.14
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$13.37
(4.1%)
Support & Resistance Levels
Support Level
$309.04
Resistance Level
$327.50
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.37
Wall Street Target
$345.13
(+6.6%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
28.2%
Profit Margin
7.0%
Valuation Premium vs History
+3.5% premium
PE vs Historical
16.4 vs 14.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.5%
(market-implied from PE analysis)
1-Year Target
$335.08
(+4%)
2-Year Target
$346.81
(+7%)
3-Year Target
$358.95
(+11%)
3-Yr Target (if PE normalizes)
(PE: 16→15)
PE COMPRESSION
$324.49
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 7.8%)
$491.65
(+52%)
Base:
(SPY PE: 16.4, Growth: 7.8%)
$405.29
(+25%)
Bear:
(PE: 13.9, Growth: 7.8%)
$344.49
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 26.73 | Current EPS (TTM): $12.09
Bull Case
$581.39
(+80%)
Analyst growth 63.6%, PE expands to 29.4
Base Case
$528.53
(+63%)
Market implied 63.6%, PE stable at 26.7
Bear Case
$219.73
(-32%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 8:13 AM ET
Data refreshes hourly during market hours. Next update: 9:13 AM
Data refreshes hourly during market hours. Next update: 9:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 61 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 42 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 44 HOLD |
Advanced LH Option Strategies
Professional options setups generated by AI based on today's LH price and gamma walls.
